Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 971-977

  Raaphorst, G P ^a   Maio, J ^a   Ng, C E ^a   Stewart, D J ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin; Human ovarian carcinoma; Low dose rate irradiation; Mild hyperthermia

Indexed keywords

CISPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MULTIMODALITY CANCER THERAPY; OVARY CANCER; PRIORITY JOURNAL; RADIATION DOSE;

CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; OVARIAN NEOPLASMS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0031842005     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.971     Document Type: Article

References (71)

1. Gerner EW (ed): Proceedings of the 6th Congress on Hyperthermic Oncology. (Vol. I and II). Arizona Board of Regents, Tucson, Arizona, 1992.
2. Raaphorst GP: Thermal radiosensitization in vitro. In: Hyperthermia and Oncology. Urano M and Douple E (eds). Vol. 2. VSP, Utrecht, pp 17-51, 1989.
3. Raaphorst GP, Mao JP and Ng CE: Sublethal radiation damage repair and its inhibition by hyperthermia in two human melanoma cell lines of different radiosensitivity. Melanoma Res 4: 157-161, 1994.
4. Raaphorst GP and Feeley MM: Comparison of post hyperthermia radiosensitivity for survival, PLDR and polymerase activity in human glioma cells. Int J Radiat Oncol 29: 133-139, 1994.
5. Raaphorst GP, Mao JP and Ng CE: Repair of potentially-lethal damage: Its inhibition by hyperthermia in two melanoma cell lines with different radio- and heat sensitivities. Melanoma Res 3: 351-356, 1993.
6. Raaphorst GP: Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. Int J Radiat Oncol 22: 1035-1041, 1992.
7. Raaphorst GP, Freeman ML and Dewey WC: Radiosensitivity and recovery from radiation damage in cultured CHO cells exposed to hyperthermia at 42.5 and 45.5°C. Radiat Res 79: 390-402, 1979.
8. Li GC, Evans RG and Hahn GM: Modification and inhibition of repair of potentially-lethal X-ray damage by hyperthermia. Radiat Res 67: 491-501, 1976.
9. Ben Hur E, Elkind MM and Bronk BV: Thermally enhanced radioresponses of cultured Chinese hamster cells: Inhibition of repair of sublethal damage and enhancement of lethal damage. Radiat Res 58: 38-51, 1974.
10. Raaphorst GP, Feeley MM, Chu GL and Dewey WC: A comparison of hyperthermia enhancement of radiation sensitivity and DNA polymerase inactivation in human glioma cells. Radiat Res 137: 338-345, 1993.
11. Dikomey E and Jung H: Correlation between thermal radiosensitization and heat-induced loss of DNA polymerase β activity in CHO cells. Int J Radiat Biol 2: 215-221, 1993.
12. Dikomey E and Jung H: Correlation between polymerase β activity and thermal radiosensitization in Chinese hamster ovary cells. Recent Results Cancer Res 109: 35-41, 1988.
13. Jorritsma JBM, Burgman P, Kampinga HH and Konings AWT: DNA polymerase activity in heat killing and hyperthermic radiosensitization of mammalian cells as observed after fractionated heat treatments. Radiat Res 105: 307-319, 1986.
14. Mivechi N and Dewey WC: Effect of glycerol and low pH on heat-induced killing and loss of cellular DNA polymerase activities in Chinese hamster ovary cells. Radiat Res 99: 352-362, 1984.
15. Taylor SG, Murphy AK, Vannetzel JM, Colin P, Droy M, Calderelli DD, Sholt S, Yokes E, Showel JL, Huchison JC, Witt TR, Griem KL, Hartsell WF, Kies MS, Mitlal B, Rebischung JL, Coupex DJ, Desphieux JL, Robin S and lePajolec C: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12: 385-395, 1994.
16. Zietman AL, Shipley WU and Kaufman DS: The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol 27: 161-170, 1993.
17. Sledge GW: Cisplatin and platinum analogues in breast cancer. Semin Oncol 19:78-82, 1992.
18. Kuske RR, Perez CA, Grigsby PW, Lovett RD, Jacobs AJ, Galakatos AE, Camel HM and Kao MS: Phase I/II study of definitive radiotherapy and chemotherapy (cispiatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Am J Clin Oncol 12: 467-473, 1989.
19. Coughlin CT and Richmond RC: Platinum based combined modality approach for locally advanced head and neck carcinoma. Int J Radiat Oncol 115: 915-919, 1985.
20. Dewit L, Bartelink H and Rumke PH: Concurrent cis-diamminedichloroplatinum (II) and radiation treatment for melanoma metastases: a pilot study. Radiother Oncol 3: 303-309, 1985.
21. Piver MS: Ovarian carcinoma, a decade of progress. Cancer 54: 2706-2715, 1984.
22. Wilkins DE, Ng CE and Raaphorst GP: Cisplatin and low doserate irradiation in cisplatin-resistant and sensitive human glioma cells. Int J Radiat Oncol 36: 105-111, 1996.
23. Raaphorst GP, Wang G and Ng CE: Radiosensitization by cisplatin treatment in cisplatin-resistant and sensitive human ovarian carcinoma cell lines. Int J Oncol 7: 325-330, 1995.
24. Walter P, Korbelik M, Spadinger I and Skov K: Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: role of single strand breaks. Radiat Oncol Invest 1: 137-147, 1993.
25. Begg AC, Stewart FA, Dewit L and Bartelink H: Interactions between cisplatin and radiation in experimental rodent tumours and normal tissues. In: Antitumour Drug-radiation Interactions. Hill BT and Bellamy AS (eds). CRC Press, Boca Raton, Florida, pp153-170, 1990.
26. Dewit L: Combined treatment of radiation and cis-diaminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol 13: 403-426, 1987.
27. Begg AC, van der Kolk PJ, Dewit L and Bartelink H: Radiosensitization by cisplatin of RIF1 tumour cells in vitro. Int J Radiat Oncol 50: 871-884, 1986.
28. Nias AHW: Radiation and platinum drug interaction. Int J Radiat Biol 48: 297-314, 1985.
29. Dritschilo A, Piro A and Kelman AD: The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. Int J Radiat Oncol 5: 1345-1349.
30. Schwachofer JHM, Crooijmans RPMA, Hoogenhout J, Kal HB and Theeuwes AGM: Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin influence of treatment sequence. Int J Radiat Oncol 20: 1235-1241, 1991.
31. Douple EB: Interaction between cisplatin coordination complexes and radiation. In: Antitumour Drug-radiation Interactions. Hill BT and Bellamy AS (eds). CRC Press, Boca Raton, Florida, pp171-190, 1990.
32. Wallner KE and Li GC: Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol 13: 587-591, 1987.
33. Carde P and Laval F: Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. Int J Radiat Oncol 7: 929-933, 1981.
34. Szumiel I and Nias AHW: The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. Br J Cancer 33: 450-458, 1976.
35. Raaphorst GP, Doja S, Davis L, Stewart D and Ng CE: Comparison of cisplatin-hyperthermia sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 37: 574-580, 1995a.
36. Kubota N, Kakehi M and Inada T: Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. Int J Radiat Oncol 25: 491-497, 1993.
37. Urano M, Kahn J and Kenton LA: The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. Int J Hyperthermia 6: 563-570, 1990.
38. DaSilva VF, Raaphorst GP, Goyal R and Feeley MM: Drug cytotoxicity at elevated temperature. J Neurosurg 61: 883-885, 1987.
39. Enselhardt R: Hyperthermia and drugs. Recent Results Cancer Res 104: 136-203, 1987.
40. Herman TS, Sweets CC, White DM and Gerner EW: Effect of rate of heating on lethality due to hyperthermia and selected chemotherapy drugs. J Natl Cancer Inst 68: 487-492, 1982.
41. Hahn GM: Potentiation of therapy drugs and hyperthermia. Cancer Res 39: 2264-2268, 1979.
42. Supi G, Badaracco G, Cavatiere R, Natali FG and Gerco C: Influence of sequence on hyperthermia and drug combination. Hyperthermic Oncol 1: 429-431, 1994.
43. Miyahara T, Ueda K, Akaboshi M, ShimadaY, Imamura M and Utsumi H: Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diaminedichloroplatinum (II) in cultured human esophageal cancer cells. Jpn J Cancer Res 84: 336-346, 1993.
44. Fujii R, Mutak M, Niwa K, Yamada K, Aibou T, Nakagawa M, Kuwano M and Akiyama S: Active efflux for cispiatin in cisplatin-resistant human KB cells. Jpn J Cancer Res 85: 426-433, 1994.
45. Jekunen AP, Horn DK, Alcaraz JE. Eastman A and Howell SB: Cellular pharmacology of dichloro(ethylenediamine) platin II in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Res 54: 2680-2687, 1994.
46. Bosscha HT, Timmer A, Meijer C, deVries EGE, deJong B, Oosterhuis JW and Mulder H: Cis-diaminedichloroplatin (II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res 53: 5707-5713, 1993.
47. Meijer C, Mulder NH, Hospers GAP, Uges DRA and de Vries EGE: The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 62: 72-77, 1990.
48. Canon JL, Humblet Y and Symann M: Resistance to cisplatin: how to deal with the problem? Eur J Cancer 26: 1-3, 1990.
49. Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M and Hamilton TC: Increased DNA repair as a mechanism of acquired resistance to cis-diaminedichloroplatinum II in human ovarian cancer cell lines. Cancer Res 48: 5713-5716, 1988.
50. Eastman A and Schulte N: Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry 27: 4730-4734, 1988.
51. Micetich K, Zwelling L and Kohn KW: Quenching of DNA: platinum (II) monoadducts as a possible mechanism of resistance to cis-diaminedichloroplatinum (II) in L1210 cells. Cancer Res 43: 3609-3613, 1983.
52. Raaphorst GP, Yang DP, Grewaal D, Stewart D, Goel R and Ng CE: Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncol Rep 2: 1037-1043, 1995.
53. Ireland CM, Pittman SM, Jones SL and Harnett PR: Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines. Anticancer Res 14: 2397-2404, 1994.
54. Britten RA, Warenius HM, Carraway AV and Murray D: Differential modulation of radiosensitivity following induction of cisplatia resistance in radiation-sensitive and radiation-resistant human tumour cells. Radiat Oncol Invest 2: 25-31, 1994.
55. Oshita F, Fujiwara Y and Saigo N: Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. J Cancer Res Clin Oncol 119: 28-34, 1992.
56. Hall EJ: Radiobiology for the Radiologist. JB Lippincott Company, Philadelphia, pp107-132, 1994.
57. Hamilton TC, Lai GM, Rothenberg LM, et al: Mechanisms of resistance to cisplatin and alkylating agents. In: Drug Resistance in Cancer Therapy. Ozols RF (ed). Boston, Kluwer Academic Publishers, pp 151-169, 1989.
58. Lai GM, Ozols RF, Smyth JF, et al: Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem Pharmacol 37: 4597-4600, 1988.
59. Raaphorst GP, Wang G, Stewart DJ, et al: Concomitant low dose rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Int J Radiat Biol 69: 623-631, 1996.
60. Fu KK, Lam KN and Rayner PA: The influence of time sequence of cisplatin administration and continuous low doserate irradiation (LDRI) on their combined effects on murine squamous cell carcinoma. Int J Radiat Oncol 11: 2119-2124, 1985.
61. Da Silva V, Gutin PH, Hoff MHB, Bernstein MA, Deen DF and Weaver KA: The effect of combination treatment with cisplatin and low dose-rate 1251 radiation in a murine rachytherapy model. Int J Radiat Oncol 10: 1471-1472, 1984.
62. Douple EB, Wills ML and Jones E: Radiopotentiation in a murine tumour (MTG-B) by continuous infusion platinum. In: Concomitant Continuous Infusion Chemotherapy and Radiation. Springer-Verlag, New York, pp191-196, 1991.
63. Fu KK, Lam KN and Rayner PA: Effects of continuous low dose-rate irradiation and concurrent infusion of mitomycin, cisplatin and 5 flurouracil on three murine tumours. Endocuriether/Hypertherm Oncol 2: 157-162, 1986.
64. Fu KK, Rayner PA and Lam KN: Modification of the effect of continuous low dose-rate irradiation by concurrent chemotherapy infusion. Int J Radiat Oncol 10: 1431-1478, 1984.
65. Konings AWT, Hettinga JVE, Lemstra W, Humphrey GB and Kapinga HH: Sensitizing for cisplatin action by hyperthermia in resistant cells. Int J Hyperthermia 9: 553-562, 1993.
66. Wondergem J, Siddik ZH, Strebel FR and Bull JMC: Effect of whole body hyperthermia on cis-diaminedichtoroplatinum (II)-induced antitumour activity and tissue Pt-distribution. Do anaesthetics influence the therapeutic ratio? Eur J Cancer 29A: 549-554, 1993.
67. Amichetti M, Graiff C, Fellin G, Pani G, Boloner A, Maluta S and Valdagni R: Cisplatin, hyperthermia and radiation (trimodal therapy) in patients with locally advanced head and neck tumours: a phase I-II study. Radiat Oncol 26: 801-807, 1993.
68. Herman TS and Teicher BA: Sequencing of trimodality therapy (cisdiaminedichloroplatinum/hyperthermia/radiation) as determined by tumour growth delay and tumour cell survival in the FSa II C fibrosarcoma. Cancer Res 48: 2693-2697, 1988.
69. Wilkins DE, Ng CE and Raaphorst GP: Cell cycle perturbations in cisplatin sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation. Cancer Chemother Pharmacol 40: 159-166, 1997.
70. Raaphorst GP, Wang G, Stewart D, et al: A study of cisplatin-radiosensitization through inhibition of repair of sublethal radiation damage in ovarian carcinoma cells sensitive and resistant to cisplatin. Int J Oncol 7: 1373-1378, 1995.
71. Raaphorst GP, Miao J and Ng CE: Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells. Cancer Chemother Pharmacol (In press).